- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: carfilzomib
Total 227 results
-
AmgenCompletedExtensive-Stage Small-Cell Lung CancerCanada, United States, Russian Federation
-
European Myeloma NetworkSanofi; Amgen; EMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Germany, Greece, Italy, Netherlands, Norway, Spain
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsRecruiting
-
AmgenActive, not recruitingRelapsed Refractory Multiple MyelomaIndia
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, United Kingdom, Netherlands, France, Australia
-
Intergroupe Francophone du MyelomeBristol-Myers Squibb; Sanofi; AmgenActive, not recruiting
-
Duke UniversityBristol-Myers SquibbWithdrawnLung Transplant Rejection | Antibody-mediated Rejection
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
TakedaActive, not recruitingMultiple MyelomaUnited States, Switzerland, Belgium, Spain, Israel, Italy, Austria, Canada, United Kingdom
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
AmgenCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterAmgenCompleted
-
AmgenOnyx Therapeutics, Inc.CompletedRelapsed and Refractory Multiple MyelomaChina
-
AmgenCompletedLymphoma | Small Cell Lung Cancer | Multiple Myeloma | Ovarian Cancer | Non-small Cell Lung Cancer | Solid Tumors | Renal CancerUnited States
-
National Cancer Institute (NCI)Janssen Scientific Affairs, LLCRecruiting
-
PETHEMA FoundationAdknoma Health ResearchRecruitingRelapsed Multiple MyelomaSpain
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; PPD; Rho Federal Systems Division, Inc.; Immune Tolerance...RecruitingHighly Sensitized Prospective Kidney Transplant RecipientsUnited States
-
University of NebraskaM.D. Anderson Cancer CenterTerminatedCabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaMultiple Myeloma | Refractory Multiple Myeloma | Relapsed/Refractory Multiple MyelomaUnited States
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Emory UniversityOnyx Therapeutics, Inc.TerminatedMultiple MyelomaUnited States
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States, Canada
-
AmgenCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma | Waldenstrom's Macroglobulinemia | Hodgkin's DiseaseUnited States
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, Canada, United Kingdom, New Zealand, Brazil
-
Hackensack Meridian HealthSuspendedMultiple MyelomaUnited States
-
Lars GullestadHelsinki University Central Hospital; Aarhus University Hospital; Rigshospitalet... and other collaboratorsCompletedCardiac Allograft VasculopathyDenmark, Finland, Sweden
-
University of Alabama at BirminghamRecruitingMultiple MyelomaUnited States
-
Wake Forest University Health SciencesIncyte Corporation; Amgen; Multiple Myeloma Research ConsortiumCompletedMultiple MyelomaUnited States
-
Loyola UniversityAmgenRecruiting
-
OncotherapeuticsAmgenUnknownMultiple MyelomaUnited States
-
AbbVieGenentech, Inc; Onyx Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States, Australia, Hungary, Puerto Rico, Spain
-
Mario Negri Institute for Pharmacological ResearchActive, not recruiting
-
Criterium, Inc.AmgenCompletedAmyloidosis | Systemic Light Chain AmyloidosisUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada
-
AmgenCompletedMultiple MyelomaKorea, Republic of, Spain, Taiwan, Canada, Australia, Israel, Italy, United States, Singapore, New Zealand, Japan, Thailand, Brazil, United Kingdom, Hungary, Czechia, Romania, Slovakia, France, Germany, Russian Federation, Bulgaria, Belgiu... and more
-
Emory UniversityAmgenCompletedNeoplasms | MalignanciesUnited States
-
Karyopharm Therapeutics IncWithdrawnMultiple MyelomaUnited States
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
University of Alabama at BirminghamAmgenCompletedPhase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentMetastatic Castration-resistant Prostate CancerUnited States
-
Thomas Martin, MDSanofi; AmgenActive, not recruitingMultiple MyelomaUnited States, Canada
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
University Hospital, LilleAmgenUnknown
-
University of California, San FranciscoNational Comprehensive Cancer NetworkCompletedLymphoma | Lymphoma, Non-HodgkinUnited States
-
Nantes University HospitalCompleted
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Spain, United Kingdom
-
Memorial Sloan Kettering Cancer CenterCelgene; Onyx/AmgenActive, not recruiting
-
Fondazione Italiana Linfomi ONLUSActive, not recruiting
-
Hackensack Meridian HealthOnyx Therapeutics, Inc.CompletedWaldenstrom MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteAmgenCompletedWaldenstrom's MacroglobulinemiaUnited States